Scholars Central

Research articlePublished 2015

Impact of Art Mother and Child on The HIV Status of the Child Born to HIVPositive Mothers in Burkina Faso: Towards the Adoption of an Effective Pmtct Policy

Authors: Sourabie Y, Ouedraogo SM, Bazie WW, Sanodji N, Barro M, Ouattara ABI, Traoré Y, Nacro B

Journal of Hematology & Thromboembolic Diseases

Volume 3 · Issue 2 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: To evaluate the impact of ART of the mother and the child on the HIV status of children born to HIV positive mothers in compliance with the policy of mother-child transmission (PMTCT) adopted in Burkina Faso. Method: It is a prospective cohort study. 214 HIV-positive mother - infant pairs were involved over a period of 14 months (2011-2013). Early pediatric laboratory biologic diagnosis of HIV infection with children aged from 6 weeks to 18 months was carried out by RNA/PCR of HIV1 (Kit Biocentric®). Children with viral load lower than 300 copies/mL (>2.48 Log) were considered uncontaminated. All the children were clinically and biologically followed up to 18 months, the age at which an immunochromatographic test (Determine®) and an ELISA test (Immunocoomb II BiSpot HIV1 2®) were made to confirm their serological status. We determined the immunological status of positive mothers through a numeration of TCD4 + lymphocytes on a flow cytometer (FacscountV1.5). HIV positive Women were dispatched following treatment systems in accordance with options A and B + (mothers on nevirapine alone, mothers on highly active antiretroviral therapy (HAART)/mothers without HAART). Results: The median age of the children was 6 months (1.5-18 months). The sex ratio was 0.79. The infection rate was 11.2% (24/214). The MTCT was significantly higher among mothers without HAART on Nevirapine only (22/41) than among those on HAART (2/172) p=0.0000 2. The proportion of children infected through breastfeeding whose mothers were not on HAART (23/23) was significantly higher than those whose mothers were on HAART (0/139) p=0.0000 12. Conclusion: According to the guidelines combined on the use of antiretroviral for the treatment and prevention of HIV infection (June 2013), we also recommend for Burkina Faso, the abandonment of Option A and the adoption of option B + with all pregnant women whatever their immune-clinical status.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Hematology & Thromboembolic Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hematology & Thromboembolic Diseases
  • SubjectHaematology
  • BylineArticles whose byline prints “Sourabie Y”
  • BylineArticles whose byline prints “Ouedraogo SM”
  • BylineArticles whose byline prints “Bazie WW”
  • BylineArticles whose byline prints “Sanodji N”
  • BylineArticles whose byline prints “Barro M”
  • BylineArticles whose byline prints “Ouattara ABI”
  • BylineArticles whose byline prints “Traoré Y”
  • BylineArticles whose byline prints “Nacro B”